Qiagen Rises as Profit Forecast Tops Estimates

Qiagen NV, a maker of medical diagnostic equipment, increased to its highest value in two-and-a-half years after forecasting 2013 profit that exceeded analysts’ estimates.

Qiagen climbed 6.8 percent to 15.66 euros in Frankfurt, the highest closing price since July 15, 2010, giving the company a market value of 3.6 billion euros ($4.9 billion).

Adjusted earnings this year will rise to about $1.16 to $1.18 a share, Qiagen said in a statement late yesterday. Analysts had predicted profit of $1.12, the average of 31 estimates compiled by Bloomberg.

Qiagen is based in Venlo, the Netherlands, with management offices in Hilden, Germany.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE